Supernus Pharma
SUPN----
Forecast & Rating4 analysts currently cover Supernus Pharma, of which 3 give a positive rating. The average price target is $60.50, about 46.8% upside from the current price of $41.21. Coverage is limited, so the data is for reference only. Data as of Oct 21, 2026; this does not constitute investment advice.
Oct 21, 2026Price forecast
$60.5046.81%
Forecast & RatingBuy
4analysts
- Strong buy75.00%
- Buy0.00%
- Hold25.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateOct 19, 2026
Forecast met47.7%
Stock price$41.21
Avg. target$61.3
High target$65
Low target$55
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.